| Nicholas J Tarricone, MD, MHA, FACOG | |
|
2000 N Village Ave, Suite 109, Rockville Centre, NY 11570-1078 | |
| (516) 678-4000 | |
| (516) 678-9573 |
| Full Name | Nicholas J Tarricone |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 2000 N Village Ave, Rockville Centre, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255371449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 176675 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai South Nassau | Oceanside, NY | Hospital |
| Mercy Medical Center | Rockville centre, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Care Pc | 9931013240 | 997 |
News Archive
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
The Washington Post examines the deaths of some hospice patients who were not close to death but who received large doses of powerful pain-killers.
For patients with dialysis-related anemia, the risk of death is increased when hemoglobin levels remain persistently low over a period several months - not necessarily when they fluctuate over time, according to a study in the January Clinical Journal of the American Society of Nephrology.
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
According to a study at Yale, one of the most effective ways to change negative attitudes about obese people is by addressing perceptions of normative beliefs within particular social groups.
› Verified 7 days ago
| Entity Name | Optum Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
The Washington Post examines the deaths of some hospice patients who were not close to death but who received large doses of powerful pain-killers.
For patients with dialysis-related anemia, the risk of death is increased when hemoglobin levels remain persistently low over a period several months - not necessarily when they fluctuate over time, according to a study in the January Clinical Journal of the American Society of Nephrology.
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
According to a study at Yale, one of the most effective ways to change negative attitudes about obese people is by addressing perceptions of normative beliefs within particular social groups.
› Verified 7 days ago
| Entity Name | Prohealth Care Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
The Washington Post examines the deaths of some hospice patients who were not close to death but who received large doses of powerful pain-killers.
For patients with dialysis-related anemia, the risk of death is increased when hemoglobin levels remain persistently low over a period several months - not necessarily when they fluctuate over time, according to a study in the January Clinical Journal of the American Society of Nephrology.
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
According to a study at Yale, one of the most effective ways to change negative attitudes about obese people is by addressing perceptions of normative beliefs within particular social groups.
› Verified 7 days ago
| Entity Name | Optum Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285975797 PECOS PAC ID: 8628299518 Enrollment ID: O20141017000598 |
News Archive
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
The Washington Post examines the deaths of some hospice patients who were not close to death but who received large doses of powerful pain-killers.
For patients with dialysis-related anemia, the risk of death is increased when hemoglobin levels remain persistently low over a period several months - not necessarily when they fluctuate over time, according to a study in the January Clinical Journal of the American Society of Nephrology.
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
According to a study at Yale, one of the most effective ways to change negative attitudes about obese people is by addressing perceptions of normative beliefs within particular social groups.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas J Tarricone, MD, MHA, FACOG 2000 N Village Ave, Suite 109, Rockville Centre, NY 11570-1078 Ph: (516) 678-4000 | Nicholas J Tarricone, MD, MHA, FACOG 2000 N Village Ave, Suite 109, Rockville Centre, NY 11570-1078 Ph: (516) 678-4000 |
News Archive
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
The Washington Post examines the deaths of some hospice patients who were not close to death but who received large doses of powerful pain-killers.
For patients with dialysis-related anemia, the risk of death is increased when hemoglobin levels remain persistently low over a period several months - not necessarily when they fluctuate over time, according to a study in the January Clinical Journal of the American Society of Nephrology.
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
According to a study at Yale, one of the most effective ways to change negative attitudes about obese people is by addressing perceptions of normative beliefs within particular social groups.
› Verified 7 days ago
Dr. Francine Amelia Guzman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Suite 104, Rockville Centre, NY 11570 Phone: 516-678-4222 Fax: 516-678-0919 | |
Carolyn Oh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 371 Merrick Rd, Suite 203, Rockville Centre, NY 11570 Phone: 516-766-7626 Fax: 516-766-0744 | |
Peter Sticco, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Village Ave Ste 204, Rockville Centre, NY 11570 Phone: 516-705-2206 | |
Dr. Joan Haselkorn-lomasky, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 556 Merrick Rd, Suite 200, Rockville Centre, NY 11570 Phone: 516-255-2044 Fax: 516-255-2045 | |
Neal H Bellin, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Suite 103, Rockville Centre, NY 11570 Phone: 516-684-9100 Fax: 516-764-2051 | |
Dr. Jonathan Yaakov Rosner, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8 N Oceanside Rd, Rockville Centre, NY 11570 Phone: 516-632-4636 Fax: 516-992-0802 |